Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
1.
Eur J Obstet Gynecol Reprod Biol ; 85(2): 191-8, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10584634

ABSTRACT

OBJECTIVE: The aim of this study was to compare routine prenatal care in nine European obstetrics and gynaecology departments. STUDY DESIGN: A survey was performed between October 1992 and November 1993 by means of a questionnaire. The questionnaire comprised 118 questions covering clinical examinations and investigations systematically performed during the pregnancy. RESULTS: The survey revealed a certain number of differences between the types of prenatal care performed by each department. Thus, one notices differences to do the serological testing (toxoplasmosis, AIDS and hepatitis B) at the first visit and in the practice of vaginal examination, systematic ultrasound examination or cardiotocography. CONCLUSION: The differences observed in the prenatal care furnished are only a reflection of our uncertainties concerning the validity of the various tests used to monitor pregnancies. At a time when financial restrictions impose choices, we consider an evaluation of the efficacy and cost of prenatal care to be essential.


Subject(s)
Gynecology , Obstetrics , Prenatal Care , Acquired Immunodeficiency Syndrome/diagnosis , Cardiotocography/statistics & numerical data , Europe , Female , Glycosuria , Hepatitis B/diagnosis , Humans , Physical Examination , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Proteinuria , Serologic Tests , Surveys and Questionnaires , Toxoplasmosis/diagnosis , Ultrasonography, Prenatal/statistics & numerical data , Vagina
2.
J Gynecol Obstet Biol Reprod (Paris) ; 28(5): 456-61, 1999 Sep.
Article in French | MEDLINE | ID: mdl-10566165

ABSTRACT

Massive feto maternal hemorrhage is rare. Early diagnosis is important because massive feto-maternal hemorrhage has a poor prognosis. The clinical manifestations of transplacental hemorrhage are related not only to the size of the hemorrhage but also to the time at which the hemorrhage occurs. In women who are candidates for Rh immune prophylaxis, massive feto maternal hemorrhage may be detected by Kleihauer test and we suggest that 10 micrograms dose of immune globin should be administered for each estimated ml of Rh positive blood given, to prevent an immunization Disappearance of fetal cells by Kleihauer test or appearance residual antibody suggests the adequacy of therapy. Three cases of massive fetomaternal hemorrhage (more than 225 ml) are presented here. Two mothers was Rh negative and they are delivered of rhésus positive children, which necessitated the administration of large volume of anti D. One of the cases shows the possibility of association between choriocarcinoma and positive kleihauer test.


Subject(s)
Fetomaternal Transfusion , Adult , Choriocarcinoma/complications , Female , Fetomaternal Transfusion/complications , Humans , Pregnancy , Rh Isoimmunization , Uterine Neoplasms/complications
3.
Eur J Obstet Gynecol Reprod Biol ; 80(2): 133-7, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9846655

ABSTRACT

OBJECTIVES: This study documents biological (haematocrit variations) and therapeutic parameters (salbutamol doses, volumes perfused) in two groups tocolysed with salbutamol, one with and the other without APO in order to define the risk factors linked to APO and to establish a standard protocol of management. STUDY DESIGN: This retrospective study includes data from 68 intravenous salbutamol tocolysis with four resulting APOs, carried out between January 1st, 1993 and December 31st, 1995. RESULTS: There was an excessive level of salbutamol administered over 48 h in the complicated APO-group (122.5+/-52 mg) opposed to the non-APO group (44.9 21 mg) as well as an overload of perfused solute (3.1+/-1.11) versus (1.9+/-1.11). Blood hemodilution was demonstrated in the APO group with a decrease of haematocrit by over 10% between the admission and the control value. No other risk factor was found. CONCLUSION: Tocolysis should be administered at the lowest possible perfusion rate with incremental doses as long as the heart rate stays under 120 beats/min and stopped after 48 h. Administration of maximal 11 of solute perfused/day is recommended. For the patient's follow-up we estimate daily input and output fluid to avoid hydric overload, and a daily control of haematocrit whose variation must be less than 10%.


Subject(s)
Adrenergic beta-Agonists/adverse effects , Albuterol/adverse effects , Pulmonary Edema/chemically induced , Pulmonary Edema/prevention & control , Tocolytic Agents/adverse effects , Acute Disease , Adrenergic beta-Agonists/therapeutic use , Adult , Albuterol/administration & dosage , Albuterol/therapeutic use , Female , Heart Rate , Hematocrit , Humans , Pregnancy , Retrospective Studies , Time Factors , Tocolysis
4.
Ultrasound Obstet Gynecol ; 12(4): 271-5, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9819860

ABSTRACT

Although the practice of perinatal autopsy has increased in recent years, examination of the fetus and especially of the fetal brain during the first trimester or the beginning of the second trimester remains difficult. Postmortem high-resolution images of the brain of a normal and an abnormal fetus of the same gestational age (22 weeks) were obtained with a low-field (0.1 T) dedicated magnetic resonance imaging (MRI) system. We demonstrated that a small MRI machine supplemented data from classical necropsy and may help in the interpretation of in utero ultrasound and magnetic resonance images for the antenatal diagnosis of fetal malformations.


Subject(s)
Brain/pathology , Fetus/pathology , Magnetic Resonance Imaging/methods , Adult , Autopsy/methods , Brain/embryology , Female , Gestational Age , Holoprosencephaly/pathology , Humans , Magnetic Resonance Imaging/instrumentation , Pregnancy
5.
J Gynecol Obstet Biol Reprod (Paris) ; 27(1): 62-70, 1998 Jan.
Article in French | MEDLINE | ID: mdl-9583047

ABSTRACT

For more than twenty-five years, the cesarean rate in France, as in other developed countries, has continued to increase, and in 1995 was 15.9%. Cesareans are now taken for granted by the general public, who are usually unaware of their consequences for maternal mortality and morbidity and continue to consider this form of delivery as the safest for the new born child. Yet it has been clearly demonstrated that cesarean deliveries are associated with higher rates of maternal and perinatal morbidity than vaginal deliveries and that they increase maternal mortality by a factor of from 5 to 7. From an economic standpoint, cesareans are between two and three times more expensive than vaginal deliveries. The two main indicators which account for the increase in cesareans are cicatricial uterus and dystocia. These are indicators in which individual practitioners' normal practice and the fear of medical malpractice suits play a clear role. There appears to be a particular correlation between the proportion of cesareans and obstetricians' insurance premiums, obstetricians' own assessment of the risk of malpractice suits and the number of complaints lodged against hospitals or individual doctors. Cesareans performed on grounds of fetal suffering or breech deliveries represent a diminishing proportion of the total. The use of scalp pH and radiopelvimetry have made it possible to restrict the number of cesareans based on these indicators. Other factors play a role in this increase, such as parity, education level, type of maternity insurance, whether the hospital is private or public, whether or not there is a neonatal resuscitation unit, the size of the city and the obstetrician's experience and type of training. The time and day or delivery have also been shown to be relevant factors. For obstetricians themselves, the higher fees earned from cesareans do not appear to be important. Of more relevance is the opportunity they offer doctors to organise their schedule and save time. Among the various methods proposed for reducing the cesarean rate, a strict definition of and respect for the indications for a cesarean, involving comparisons between establishments and between practitioners, have been shown to be effective. To allow such figures to be compiled, France should therefore produce for each confinement a standard record containing the different perinatal data, as is already the case in numerous other countries.


Subject(s)
Cesarean Section/statistics & numerical data , Cesarean Section/adverse effects , Cesarean Section/mortality , Cesarean Section/trends , Female , France/epidemiology , Health Knowledge, Attitudes, Practice , Humans , Patient Selection , Residence Characteristics , Risk Factors
7.
Obstet Gynecol ; 91(2): 196-202, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9469275

ABSTRACT

OBJECTIVE: To evaluate the activity of the renin-angiotensin-aldosterone system in the circulation during the three trimesters of normal pregnancy and in women with preeclampsia. METHODS: Normal pregnant volunteers (n = 7) were studied throughout pregnancy, and women with preeclampsia (n = 8) were studied in the third trimester. Plasma active renin and aldosterone were measured by radioimmunoassay. Angiotensin I and angiotensin II were determined by radioimmunoassay after separation of the peptides by high-performance liquid chromatography. RESULTS: Active renin concentration increased in the first trimester of normal pregnancy, whereas angiotensin I, angiotensin II, and aldosterone remained at a level comparable to the postpartum values. Highest activity of the renin-angiotensin-aldosterone system was observed during the third trimester with increased levels of angiotensin I, angiotensin II, and aldosterone. In contrast, in patients with preeclampsia, despite a slight increase of active renin levels, the other parameters of the renin-angiotensin-aldosterone system were low compared with the third trimester of normal pregnancy and were comparable to postpartum data. CONCLUSION: Our results suggest that during the first trimester of normal pregnancy, active renin concentration in the plasma is increased and that renin is not the factor that limits angiotensin II synthesis. These results also confirm decreased activity of the renin-angiotensin-aldosterone system in preeclampsia. This could contribute to the diminished hemodynamic control observed in pregnant women developing preeclampsia.


Subject(s)
Angiotensin II/blood , Angiotensin I/blood , Pre-Eclampsia/blood , Pregnancy/blood , Renin/blood , Adult , Female , Humans , Renin-Angiotensin System
8.
J Obstet Gynaecol ; 18(2): 127-32, 1998 Mar.
Article in English | MEDLINE | ID: mdl-15512029

ABSTRACT

We conducted a meta-analysis of the mortality and morbidity of the breech presentation according to the method of delivery. Using the term 'breech', we used the Medline data base to search the English and French-language literature from 1978 to July 1995. Twenty-two studies (7239 deliveries) were found and analysed. The meta-analysis concerning perinatal mortality did not reveal a significant increased risk, when vaginal deliveries were compared with those delivered by a caesarean section (odds ratio: 1.90; confidence interval: 0.59-8.22) or when vaginal deliveries were compared with those done by planned caesarean section (odds ratio: 4.95; confidence interval: 0.44-80.06). The neonatal morbidity showed an increased risk with vaginal delivery. It is concluded that the practice of resorting to caesarean section for every breech presentation at term does not seem defensible.

9.
Acta Obstet Gynecol Scand ; 76(3): 218-21, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9093134

ABSTRACT

OBJECTIVE: The purpose was to determine to what extent fetal fibronectin was a discriminative test of preterm delivery in patients hospitalized for uterine contractions without modification of the cervix. STUDY DESIGN: The prospective double-blind study included patients hospitalized between 24 and 34 week for false labor. Cervicovaginal swabs were obtained and assayed for the presence of fetal fibronectin by means of a monoclonal antibody assay. RESULTS: Out of the 61 patients included, 18 showed a positive swab. The correlation of a positive result with preterm delivery revealed a sensitivity of 56%, a specificity of 81%, and positive and negative predictive values of 56% and 81% respectively. Meta-analysis of studies published shows that the presence of fibronectin represents a significant relative risk of 3.3 (IC: 2.5-42) of preterm delivery. CONCLUSION: The presence of fetal fibronectin in cervicovaginal secretions of patients presenting with false labor indicates a major risk of preterm delivery.


Subject(s)
Cervix Uteri/chemistry , Fetus/chemistry , Fibronectins/analysis , Obstetric Labor, Premature/diagnosis , Vagina/chemistry , Adult , Antibodies, Monoclonal/analysis , Antibodies, Monoclonal/immunology , Cervix Uteri/cytology , Cervix Uteri/physiology , Double-Blind Method , Female , Fibronectins/immunology , Humans , Obstetric Labor, Premature/epidemiology , Obstetric Labor, Premature/physiopathology , Predictive Value of Tests , Pregnancy , Prospective Studies , Risk Factors , Sensitivity and Specificity , Uterine Contraction/physiology , Vagina/cytology , Vagina/physiology
10.
Article in French | MEDLINE | ID: mdl-9265060

ABSTRACT

OBJECTIVE: The purpose of this study was to compare the routine pre-natal surveillance carried out in nine European Gyneco-Obstetric units. MATERIAL AND METHOD: A survey was carried out between October 1992 and November 1993 with the aid of a questionnaire. The questionnaire contained 118 questions covering clinical examinations and explorations undertaken systematically during the first, second and third trimesters and at the end of pregnancy before delivery. To ensure that the replies were accurate, the survey was carried out on the spot in the units concerned with the head of the unit. RESULTS: The survey revealed a certain number of differences in the surveillance carried out in the various units. The units did not all carry out systematic blood tests for toxoplasmosis, AIDS and hepatitis B at the first examination. The same applied to fasting blood glucose and the bacterial culture of the urine. Nor did all the units automatically undertake vaginal examination during the second and third trimesters and the English departments were not all convinced of the need for systematic ultrasound tests. Only five of the nine units undertook routinely cardiotocographic recordings of the fetal heart rate at the end of the pregnancy. CONCLUSION: The differences observed in the various surveillance procedures simply reflect our uncertainty regarding the different tests we use to monitor pregnancies. At a time when financial constraints are forcing us to make choices, there is an urgent need to assess the effectiveness and the cost of the various elements of our prenatal monitoring.


Subject(s)
Prenatal Care/methods , Cardiotocography , Diagnostic Tests, Routine , Europe , Female , Humans , Obstetrics and Gynecology Department, Hospital , Physical Examination , Pregnancy , Surveys and Questionnaires , Ultrasonography, Prenatal , Urine/microbiology , Vagina
11.
Fetal Diagn Ther ; 12(5): 286-91, 1997.
Article in English | MEDLINE | ID: mdl-9430210

ABSTRACT

At 28 weeks of amenorrhea, 1 fetus of a monoamniotic twin pregnancy died. Ultrasound and Doppler investigations of the surviving twin were normal. Three weeks later, endovaginal ultrasound and magnetic resonance imaging revealed massive bilateral cerebral ischemic necrosis in the surviving twin. In utero fetal blood sampling carried out before the termination did not reveal either anemia or thrombopenia. Current data suggest that cerebral or renal ischemic complications could set in immediately after the death of the first twin as a result of a period of acute hypotension. At least 2 weeks are necessary for them to be identifiable by ultrasound. It seems that they cannot be prevented by prompt delivery of the second twin.


Subject(s)
Amnion , Brain Injuries/embryology , Chorion , Fetal Death/complications , Pregnancy, Multiple , Twins, Monozygotic , Abortion, Spontaneous , Adult , Autopsy , Brain Injuries/diagnostic imaging , Brain Injuries/pathology , Female , Fetal Death/embryology , Fetal Death/pathology , Humans , Magnetic Resonance Imaging , Pregnancy , Pregnancy Trimester, Second , Ultrasonography, Doppler, Color , Ultrasonography, Prenatal
12.
Bone Marrow Transplant ; 18(1): 217-20, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8832020

ABSTRACT

Congenital erythropoietic porphyria (Gunther's disease, GD) is a rare autosomal recessive disease. It results from the deficiency of uroporphyrinogen III synthase, the fourth enzyme on the metabolic pathway of heme synthesis. GD leads to severe scarring of the face and hands as a result of photosensitivity and fragility of the skin due to uroporphyrin I and coproporphyrin I accumulation. It also causes erythrocyte fragility leading to haemolytic anaemia. The other clinical features include hirsutism, red discolouration of teeth, finger-nails and urine and stunted growth. The outcome is poor, and the disfiguring nature of GD may partly explain the legend of the werewolf. No curative treatment was known until 1991, when the first case of BMT in GD was reported. The clinical and biological outcome after transplantation was encouraging, with an important regression of the symptoms of the disease, but the child died of CMV-infection 11 months after BMT. We report the second case of GD treated successfully by stem cell transplantation using umbilical cord blood from an HLA-identical brother in a 4-year-old girl suffering from severe GD. Our patient is very well 10 months after transplantation. We confirm that stem cell transplantation is curative for GD.


Subject(s)
Fetal Blood/cytology , Hematopoietic Stem Cell Transplantation , Porphyria, Erythropoietic/therapy , Amniocentesis , Combined Modality Therapy , Female , Fetal Diseases/diagnosis , Fetal Diseases/genetics , Humans , Infant , Infant, Newborn , Male , Porphyria, Erythropoietic/diagnosis , Porphyria, Erythropoietic/genetics , Porphyria, Erythropoietic/surgery , Pregnancy , Splenectomy , Transplantation Conditioning
13.
Fetal Diagn Ther ; 11(3): 191-8, 1996.
Article in English | MEDLINE | ID: mdl-8739586

ABSTRACT

The criteria for the detection of fetal pyelectasis are still controversial. Prenatal and postnatal data from 2,170 consecutive pregnant women who underwent at least one antenatal ultrasound scan were prospectively studied. Fetal pyelectasis was defined on the basis of a mean renal pelvis dimension > 5 or 10 mm before or after 28 weeks of gestation, respectively. Pyelectasis was detected in 95 (4.4%) fetuses. Eighty-nine among them were explored after birth. In 13 (13.7%) cases, an obstructive urinary tract abnormality, a severe vesicoureteral reflux, or a megaureter were diagnosed postnatally. In 29 (30.5%) cases, pyelectasis was confirmed postnatally, while complementary investigations ruled out an obstruction of the urinary tract. The incidence of urinary tract malformations was thus 0.60%, while the positive predictive value was 13.7%. We recommend to use a value not < 10 mm of the renal pelvis mean dimension beyond 28 weeks of gestation as a threshold for detection of fetal upper urinary tract obstruction, in the absence of ureteric and/or bladder dilation. Any value between 5 and 10 mm measured during the 2nd trimester of gestation should be confirmed by a second ultrasound examination performed during the 3rd trimester, before being considered pathological.


Subject(s)
Ultrasonography, Prenatal , Urinary Tract/abnormalities , Urinary Tract/diagnostic imaging , Chromosome Aberrations , Dilatation, Pathologic/diagnostic imaging , Dilatation, Pathologic/etiology , Dilatation, Pathologic/genetics , Female , Gestational Age , Humans , Male , Pregnancy , Prospective Studies
14.
Fetal Diagn Ther ; 11(1): 37-45, 1996.
Article in English | MEDLINE | ID: mdl-8719720

ABSTRACT

The objectives of the study were to assess the ability of a fetal pulse oximeter to measure the fetal oxygen saturation (SPO2) continuously during labor and to assess the correlation between readings of fetal pulse oximetry and cord blood gases at birth. The Nellcor N-400 Fetal Oximeter was used in 62 women prospectively. The mean SPO2 was unchanged at the different stages of normal labor. 53.3 +/- 9.1 to 50.1 +/- 11.8% (n = 50). The SPO2 recorded during the pushing phase of stage II (n = 40) was correlated significantly with umbilical cord arterial pH (r = 0.55; p = 0.0002), venous pH (r = 0.63; p = 0.0001), venous PCO2 (r = 0.47; p = 0.002) and venous PO2 (r = 0.39; p = 0.01). SPO2 was also correlated with scalp pH (r = 0.52; p < 0.05; n = 21). No side effects were noted. Fetal pulse oximetry could be useful to assess fetal oxygenation during labor and at birth.


Subject(s)
Fetal Monitoring/methods , Fetus/metabolism , Labor, Obstetric/physiology , Oximetry , Oxygen/blood , Adult , Female , Gestational Age , Humans , Oximetry/methods , Pregnancy , Retrospective Studies
15.
Fetal Diagn Ther ; 11(1): 79-84, 1996.
Article in English | MEDLINE | ID: mdl-8719727

ABSTRACT

We report a case of sirenomelia of the symelia dipus type which is associated with complete situs inversus. Sirenomelia is difficult to diagnose prenatally because of a frequently associated oligohydramnios. Symelia dipus type adds to the difficulty of the diagnosis, since the bones of the thighs and legs are fully formed. In fact, a close examination of the cases of sirenomelia previously reported in the literature shows that a prenatal diagnosis was achieved only when the oligohydramnios was no more than moderate and/or the associated malformation was of apus or unipus type. We propose a systematic amnioinfusion when one suspects symelia unipus type. Finally, the pathogenesis of sirenomelia is discussed, as the presence of a complete situs inversus in the case reported here could illuminate the debate concerning the origin of the malformation.


Subject(s)
Ectromelia/diagnosis , Situs Inversus/diagnosis , Adult , Ectromelia/complications , Female , Humans , Pregnancy , Prenatal Diagnosis , Situs Inversus/complications
16.
Ultrasound Obstet Gynecol ; 6(1): 33-9, 1995 Jul.
Article in English | MEDLINE | ID: mdl-8528798

ABSTRACT

The prenatal diagnosis of pulmonary sequestration can usually be made by the third trimester of pregnancy, from the combination of an intrathoracic mass and indirect signs such as cardiac deviation, fetal hydrops, pleural effusion and polyhydramnios. We describe four cases in which pulmonary hyperechogenicity was detected before 26 weeks' gestation. In three cases the hyperechogenic mass was isolated. In all cases it had mostly regressed during the pregnancy. A review of the cases of isolated pulmonary sequestration that have been diagnosed during the antenatal period is presented. Antenatal evolution was found to be unpredictable regardless of the type or severity of the case at the first diagnosis. We propose a classification to define more clearly the optimal management of pulmonary sequestration.


Subject(s)
Bronchopulmonary Sequestration/physiopathology , Fetal Diseases/physiopathology , Lung/physiopathology , Ultrasonography, Prenatal , Adult , Bronchopulmonary Sequestration/diagnostic imaging , Bronchopulmonary Sequestration/embryology , Female , Fetal Diseases/diagnostic imaging , Fetal Diseases/embryology , Gestational Age , Humans , Lung/diagnostic imaging , Lung/embryology , Magnetic Resonance Imaging , Pregnancy , Remission, Spontaneous , Tomography, X-Ray Computed , Ultrasonography, Doppler, Color
17.
Fetal Diagn Ther ; 9(3): 155-8, 1994.
Article in English | MEDLINE | ID: mdl-8060510

ABSTRACT

The authors describe the first case of an isolated bilateral radial ray reduction occurring in a fetus exposed in utero to valproic acid; the diagnosis was made by ultrasound during the second trimester. This case of an isolated radial ray reduction associated with valproic acid use in pregnancy is a reminder for sonographers to carefully examine not only the cardiac and neurologic system, but also the extremities, when a fetus is exposed in utero to valproic acid.


Subject(s)
Abnormalities, Drug-Induced , Maternal-Fetal Exchange , Radius/abnormalities , Valproic Acid/adverse effects , Adult , Epilepsy/drug therapy , Female , Humans , Pregnancy , Pregnancy Complications , Ultrasonography, Prenatal , Valproic Acid/therapeutic use
19.
Ultrasound Obstet Gynecol ; 4(1): 68-72, 1994 Jan 01.
Article in English | MEDLINE | ID: mdl-12797229

ABSTRACT

Two new cases of antenatal diagnosis of arachnoid cyst are described. Diagnosis was made at 2.5 and 32 weeks' gestational age. In the first case, a slight increase in the diameter of the anechoic mass was observed in the second trimester. In the second case, ventricular dilatation was present prenatally. Appropriate surgical therapy was initiated at 2 months in the first case and at 8 days in the second and the neurological development of the two children is considered as normal at 18 months of age. Major features of in utero diagnosis, treatment and follow-up are discussed.

SELECTION OF CITATIONS
SEARCH DETAIL
...